FREQUENTLY ASKED QUESTIONS FOR PROFESSIONALS
Based on its review of all data submitted by the company, in November 2020 the FDA cleared NightWare for the reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD). It is not intended to be used alone and should not be used by patients who have acted out their nightmares (i.e., sleep walking, violence).
REQUEST A MEETING
We would appreciate the opportunity to speak with you in greater detail about NightWare and how it might fit into your treatment algorithm. Please visit our Contact page, provide us with your information, and we will respond within three business days to schedule a meeting.